Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
US Army
Argus Health

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,013,743

« Back to Dashboard

Summary for Patent: 5,013,743

Title: Selective antibacterial agent against campytobacter
Abstract:The compound represented by the formula; ##STR1## [wherein R.sup.1 stands for hydrogen, methoxy or trifluoromethyl; R.sup.2 and R.sup.3, being the same or different from each other, stand for hydrogen or methyl; R.sup.4 stands for optionally substituted hydrocarbon residue; and n denotes 0 or 1] or a salt thereof show excellent antibacterial activities, against the genus Campylobacter, especially against Campylobacter pylori, and they are used for preventing or treating infectious diseases caused by the said bacteria.
Inventor(s): Iwahi; Tomoyuki (Suita, JP), Satoh; Hiroshi (Suita, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:07/478,405
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,013,743

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan1-032374Feb 10, 1989
Japan1-239233Sep 15, 1989

International Patent Family for Patent: 5,013,743

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69014141► Subscribe
Denmark0382489► Subscribe
European Patent Office0382489► Subscribe
Canada2009741► Subscribe
Spain2066120► Subscribe
Austria114114► Subscribe
Finland100168► Subscribe
Finland940951► Subscribe
Finland104045► Subscribe
Greece3014973► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Cantor Fitzgerald
Farmers Insurance
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus